NEWSLETTER
| LOGIN
| SIGNUP
Locate all Pharmaceutical resources, white papers, articles, blogs and videos here
NEWSLETTER
|
LOGIN
|
SIGNUP
News
Featured News
Trending News
Archive News
Events
All Events
Past Events
Upcoming Conferences
Past Conferences
Live Webinars
On-demand Webinars
Companies
Marketplace
C-Suite On Deck
Thought Leaders
Resources
Videos
Webinars
Articles
Infographics
Whitepapers
JavaScript has been disabled on your browser. The website might not work properly unless you enable it.
home.aspx
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
I agree to the
terms of service
and
privacy policy
.
.
https://pharmaceutical.report/Resources/Whitepapers/2d50d3b1-20c8-4429-b101-080df2e1c948_Teva Pharma sinks on Q1 revenue miss amid generic competition.pdf
PLEASE CORRECT THE FOLLOWING:
Please Enter Some Keywords
Teva Pharma sinks on Q1 revenue miss amid generic competition
infographic
SHARE
SHARE
SHARE
Drugmaker Teva Pharmaceutical (NYSE: TEVA) reported a decline in first-quarter adjusted earnings, owing to a 15% fall in revenues as the company continues to face stiff competition in the generic market. Though earnings surpassed analysts’ forecast, the stock dropped early Thursday.
DOWNLOAD
I'm for real
Enter your email once to access all our information and resources.
(Your email address is required so we know you're a real person)
By downloading this content, you give permission for your contact information to be shared with the content provider who may contact you in regards to the content.